InvestmentAug 13, 2026, 05:02 PM
BIO-key Raises $2.51M via Warrant Exercise; Issues New Warrants
AI Summary
BIO-key International entered into a warrant exercise agreement with an institutional investor, generating approximately $2.51 million in gross proceeds. The agreement involved reducing the exercise price of existing warrants for 618,334 shares from $10.20 to $4.06 per share and issuing new unregistered warrants for 1,236,668 shares at $4.06 per share. The new warrants require stockholder approval for exercisability. The company plans to use the net proceeds for working capital and general corporate purposes, including potential debt repayment.
Key Highlights
- Raised approximately $2.51 million in gross proceeds from warrant exercise.
- Existing warrants for 618,334 shares had exercise price reduced from $10.20 to $4.06 per share.
- Issued new unregistered warrants for 1,236,668 shares at an exercise price of $4.06 per share.
- New warrants require stockholder approval for exercisability and terminate five years after approval.
- Company to use net proceeds for working capital and general corporate purposes, including debt repayment.
- Paid Maxim Group LLC a 5.0% cash fee of gross proceeds for placement agent services.
Price Impact
More from BKYI